Tag:
TapImmune
Latest Headlines
Latest Headlines
TapImmune, Aeras team on TB vaccine
TapImmune has signed a deal with non-profit development group Aeras for preclinical work on a tuberculous vaccine. TapImmune's technology is designed to make vaccines more effective by boosting
TapImmune, Mayo Clinic announce Ph1 breast cancer vaccine trial
Seattle-based TapImmune will sponsor a Mayo Clinic Phase I study of a therapeutic breast cancer vaccine, which has received FDA IND approval. Trial recruitment, which will focus on HER-2/neu positive
